Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix? | NITAG RESOURCE CENTER

Authors:

Parker, E. P. K.

Desai, S.

Marti, M.

O'Brien, K. L.

Kaslow, D. C.

Kochhar, S.

Olayinka, F.

Cravioto, A.

Nohynek, H.

Hombach, J.

Wilder-Smith, A.

Disease:

COVID-19

Methodological quality (AMSTAR 2):

Critically low

Source(s):

https://doi.org/10.1016/S1473-3099(22)00178-5

Open access:

Yes

Date of last literature search:

Not provided

Number of studies:

48

Publication year:

2022

All age groups
COVID-19
Safety
Efficacy/effectiveness
Administration